Cargando…

Neuromodulatory therapies for patients with prolonged disorders of consciousness

BACKGROUND: Reviving patients with prolonged disorders of consciousness (DOCs) has always been focused and challenging in medical research. Owing to the limited effectiveness of available medicine, recent research has increasingly turned towards neuromodulatory therapies, involving the stimulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yue-Hao, Yu, Jie, Hong, Li-Rong, Luo, Ben-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104219/
https://www.ncbi.nlm.nih.gov/pubmed/33797467
http://dx.doi.org/10.1097/CM9.0000000000001377
_version_ 1783689447507755008
author Wu, Yue-Hao
Yu, Jie
Hong, Li-Rong
Luo, Ben-Yan
author_facet Wu, Yue-Hao
Yu, Jie
Hong, Li-Rong
Luo, Ben-Yan
author_sort Wu, Yue-Hao
collection PubMed
description BACKGROUND: Reviving patients with prolonged disorders of consciousness (DOCs) has always been focused and challenging in medical research. Owing to the limited effectiveness of available medicine, recent research has increasingly turned towards neuromodulatory therapies, involving the stimulation of neural circuits. We summarised the progression of research regarding neuromodulatory therapies in the field of DOCs, compared the differences among different studies, in an attempt to explore optimal stimulation patterns and parameters, and analyzed the major limitations of the relevant studies to facilitate future research. METHODS: We performed a search in the PubMed database, using the concepts of DOCs and neuromodulation. Inclusion criteria were: articles in English, published after 2002, and reporting clinical trials of neuromodulatory therapies in human patients with DOCs. RESULTS: Overall, 187 published articles met the search criteria, and 60 articles met the inclusion criteria. There are differences among these studies regarding the clinical efficacies of neurostimulation techniques for patients with DOCs, and large-sample studies are still lacking. CONCLUSIONS: Neuromodulatory techniques were used as trial therapies for DOCs wherein their curative effects were controversial. The difficulties in detecting residual consciousness, the confounding effect between the natural course of the disease and therapeutic effect, and the heterogeneity across patients are the major limitations. Large-sample, well-designed studies, and innovations for both treatment and assessment are anticipated in future research.
format Online
Article
Text
id pubmed-8104219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-81042192021-05-10 Neuromodulatory therapies for patients with prolonged disorders of consciousness Wu, Yue-Hao Yu, Jie Hong, Li-Rong Luo, Ben-Yan Chin Med J (Engl) Systematic Review BACKGROUND: Reviving patients with prolonged disorders of consciousness (DOCs) has always been focused and challenging in medical research. Owing to the limited effectiveness of available medicine, recent research has increasingly turned towards neuromodulatory therapies, involving the stimulation of neural circuits. We summarised the progression of research regarding neuromodulatory therapies in the field of DOCs, compared the differences among different studies, in an attempt to explore optimal stimulation patterns and parameters, and analyzed the major limitations of the relevant studies to facilitate future research. METHODS: We performed a search in the PubMed database, using the concepts of DOCs and neuromodulation. Inclusion criteria were: articles in English, published after 2002, and reporting clinical trials of neuromodulatory therapies in human patients with DOCs. RESULTS: Overall, 187 published articles met the search criteria, and 60 articles met the inclusion criteria. There are differences among these studies regarding the clinical efficacies of neurostimulation techniques for patients with DOCs, and large-sample studies are still lacking. CONCLUSIONS: Neuromodulatory techniques were used as trial therapies for DOCs wherein their curative effects were controversial. The difficulties in detecting residual consciousness, the confounding effect between the natural course of the disease and therapeutic effect, and the heterogeneity across patients are the major limitations. Large-sample, well-designed studies, and innovations for both treatment and assessment are anticipated in future research. Lippincott Williams & Wilkins 2021-04-05 2021-02-25 /pmc/articles/PMC8104219/ /pubmed/33797467 http://dx.doi.org/10.1097/CM9.0000000000001377 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Systematic Review
Wu, Yue-Hao
Yu, Jie
Hong, Li-Rong
Luo, Ben-Yan
Neuromodulatory therapies for patients with prolonged disorders of consciousness
title Neuromodulatory therapies for patients with prolonged disorders of consciousness
title_full Neuromodulatory therapies for patients with prolonged disorders of consciousness
title_fullStr Neuromodulatory therapies for patients with prolonged disorders of consciousness
title_full_unstemmed Neuromodulatory therapies for patients with prolonged disorders of consciousness
title_short Neuromodulatory therapies for patients with prolonged disorders of consciousness
title_sort neuromodulatory therapies for patients with prolonged disorders of consciousness
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104219/
https://www.ncbi.nlm.nih.gov/pubmed/33797467
http://dx.doi.org/10.1097/CM9.0000000000001377
work_keys_str_mv AT wuyuehao neuromodulatorytherapiesforpatientswithprolongeddisordersofconsciousness
AT yujie neuromodulatorytherapiesforpatientswithprolongeddisordersofconsciousness
AT honglirong neuromodulatorytherapiesforpatientswithprolongeddisordersofconsciousness
AT luobenyan neuromodulatorytherapiesforpatientswithprolongeddisordersofconsciousness